The pharmaceutical company Ferrer and the European Pulmonary Hypertension Association (PHA Europe) have joined forces in the PHantasticals awareness campaign to make people aware of Pulmonary Hypertension (PH), a progressive disease that reduces blood flow and increases pressure in the pulmonary arteries, affecting the heart and lungs. Some forms are rare and can progress rapidly, as well as being debilitating and deadly.

A recently published paper from Vascular Biosciences (VBS) has been selected by the Faculty of 1000 (F1000) as one of the top 2 percent of all published articles in the biological and medical sciences in 2011.